iScience (Nov 2020)

TACI Constrains TH17 Pathogenicity and Protects against Gut Inflammation

  • Andy Hee-Meng Tan,
  • Gloria Hoi Wan Tso,
  • Biyan Zhang,
  • Pei-Yun Teo,
  • Xijun Ou,
  • Sze-Wai Ng,
  • Alex Xing Fah Wong,
  • Sean Jing Xiang Tan,
  • Arleen Sanny,
  • Susana Soo-Yeon Kim,
  • Alison P. Lee,
  • Shengli Xu,
  • Kong-Peng Lam

Journal volume & issue
Vol. 23, no. 11
p. 101707

Abstract

Read online

Summary: TACI (transmembrane activator and calcium modulator and cyclophilin ligand interactor) plays critical roles in B cells by promoting immunoglobulin class switching and plasma cell survival. However, its expression and function in T cells remain controversial. We show here that TACI expression can be strongly induced in murine CD4+ T cells in vitro by cytokines responsible for TH17 but not TH1 or TH2 differentiation. Frequencies and numbers of TH17 cells were elevated in TACI−/− compared with wild-type mice as well as among TACI−/− versus wild-type CD4+ T cells in mixed bone marrow chimeras, arguing for a T cell-intrinsic effect in the contribution of TACI deficiency to TH17 cell accumulation. TACI−/− mice were more susceptible to severe colitis induced by dextran sodium sulfate or adoptive T cell transfer, suggesting that TACI negatively regulates TH17 function and limits intestinal inflammation in a cell-autonomous manner. Finally, transcriptomic and biochemical analyses revealed that TACI−/− CD4+ T cells exhibited enhanced activation of TH17-promoting transcription factors NFAT, IRF4, c-MAF, and JUNB. Taken together, these findings reveal an important role of TACI in constraining TH17 pathogenicity and protecting against gut disease.

Keywords